 |
BioWorld-Insight-2010-09-13
Buyers' or Sellers' Market? Depends on Your Options
Next Wave of Japanese Deal-Making: Different than Last
Japanese pharmaceutical companies are taking a broad interest in U.S. and European biotechs, but both deal-making tactics and deal structures have evolved since the last headline-grabbing go-round in 2008.